Elimination of Peritoneal Tumor Cells With Extensive Peritoneal Lavage During Surgery in Patients With Gastric Cancer
NCT01476553 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2017-05-02
Summary
A Japanese study showed that the additional use of an "Extensive Intraperitoneal Lavage" (EIPL), i.e. an extensive washing of the abdominal cavity with water, during surgery for gastric cancer can lead to a significant increase in survival. However, the study was confined to patients in whom upon commencing surgery, free peritoneal tumor cells were detected, which is only a small fraction of patients.
The primary objective of our study is to assess in all patients undergoing removal of the stomach and adjacent lymph nodes for stomach cancer, if EIPL can eliminate free peritoneal tumor cells which have been present at the beginning of the surgery or after the stomach and lymph node removal. Secondary objectives are to assess how often free peritoneal tumor cells occur in patients with stomach cancer, how often surgical resection itself leads to a release of tumor cells, the safety of the EIPL procedure, and disease-free and overall survival of patients undergoing EIPL. Based on the outcome of this japanese study we want to test with special laboratory methods why this lavage leads to a better outcome.
Specifically, the trial will test the hypotheses that a) lymph node dissection causes a release of tumor cells in the abdominal cavity, and b) EIPL eliminates free peritoneal tumor cells.
Conditions
- Adenocarcinoma
- Stomach Neoplasms
Interventions
- PROCEDURE
-
Extensive Intraperitoneal Lavage (EIPL)
EIPL is performed after completing resection and lymphadenectomy: the abdominal cavity has to be washed ten times with one liter Ringer's solution. Each liter has to be well dispersed manually in the abdominal cavity, and removed and disposed completely. 100 ml of the last liter of lavage fluid will be harvested and sent for analysis. Contrary to the Japanese trial, Ringer's solution will be used instead of normal saline solution because of a presumed higher likelihood of peritoneal adhesions when employing the latter (7). Ringer's solution is the standard used for all intraperitoneal lavage procedures at the study centre. To avoid hypothermia, the lavage fluid will be warmed to body temperature (37° Celsius).
Sponsors & Collaborators
-
Heidelberg University
collaborator OTHER -
Universitätsmedizin Mannheim
lead OTHER
Principal Investigators
-
Ulrich Ronellenfitsch, MD · University Hospital Mannheim, Department of Surgery
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-02-28
- Primary Completion
- 2013-03-31
- Completion
- 2013-03-31
Countries
- Germany
Study Locations
More Related Trials
-
Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal Cancer
NCT01116791 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase Ib/II Study of Efficacy and Feasibility of Cytoreductive Surgery, Extensive Peritoneal Lavage, Hyperthermicintraperitoneal Chemotherapy and Post-operative Intraperitoneal Chemotherapy Combination in Gastric Cancer With Peritoneal Metastasis
NCT02995850 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer
NCT04180761 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Diagnostic Value of Staging Laparoscopy and Computed Tomography Response Assessment in Patients With Gastric Adenocarcinoma
NCT05013775 ·Status: COMPLETED
-
Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stomach CAncer: a Feasibility Study
NCT03150628 ·Status: TERMINATED ·Phase: PHASE2
-
Protocol: Reconstruct the Pelvic Peritoneum Using BPF
NCT04177407 ·Status: UNKNOWN ·Phase: NA
-
Prophylactic Preoperative HIPEC in Advanced Gastric Cancer at High Risk of Peritoneal Recurrence
NCT04597294 ·Status: RECRUITING ·Phase: PHASE3
-
Thrombin Generation and Platelet Activation in CRS/HIPEC
NCT03034850 ·Status: COMPLETED
-
Response Prediction of Hyperthermic Intraperitoneal Chemotherapy in Gastro- Intestinal Cancer
NCT05652348 ·Status: RECRUITING
-
Study of Plasma Tumor-promoting Factors and Immune Function After Laparotomy, Cytoreductive Surgery and HIPEC vs. PIPAC in Patients With Peritoneal Metastasis
NCT04122885 ·Status: UNKNOWN
-
A Minimally-invasive Approach to Cytoreduction and HIPEC for Peritoneal Surface Malignancy
NCT02463877 ·Status: COMPLETED ·Phase: PHASE2
-
Preoperative/Neoadjuvant Therapy and Vascular Debranching Followed by Resection for Locally Advanced Pancreatic Cancer
NCT04136769 ·Status: TERMINATED ·Phase: NA
-
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Gastric Cancer
NCT03253939 ·Status: COMPLETED
-
Identify the Clinical Significance and Potential Implications of Peritoneal Washing Cytology (PWC) in Patients With Pancreatic Cancer
NCT01127815 ·Status: UNKNOWN
-
Quality of Life and Function of Patients With Pelvic Tumors After Undergoing Hemipelvectomy
NCT05134142 ·Status: RECRUITING
-
Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses
NCT04108936 ·Status: RECRUITING
-
An Audit of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
NCT02754115 ·Status: RECRUITING
-
Prophylactic HIPEC for Colorectal Cancers at High Risk of Developing Peritoneal Metastases
NCT03422432 ·Status: COMPLETED ·Phase: NA
-
Development of an IDEAL Framework to Standardise Cytoreductive Surgery for Colorectal Peritoneal Metastases
NCT03733184 ·Status: COMPLETED
-
Adjuvant HIPEC to Prevent Colorectal Peritoneal Metastases in High-risk Patients
NCT02575859 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Laparoscopic-assisted Total Gastrectomy Versus Open Total Gastrectomy With Splenic Hilum Lymph Nodes Dissection
NCT02711033 ·Status: UNKNOWN ·Phase: PHASE2
-
Treatment of Primary Peritoneal Carcinosis of Digestive Origin Using Cytoreductive Surgery and Hyperthermic Intraoperative Peritoneal Chemotherapy With Mitomycin C and Irinotecan
NCT01226550 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Patient Derived Vascularized MicroTumor Model of Gastrointestinal Peritoneal Carcinomatosis
NCT05844865 ·Status: RECRUITING ·Phase: NA
-
Adjuvant HIPEC in High Risk Colon Cancer
NCT02231086 ·Status: COMPLETED ·Phase: PHASE3
-
Combined Anticancer Treatment of Advanced Colon Cancer
NCT01540344 ·Status: TERMINATED ·Phase: PHASE2